Breaking News Instant updates and real-time market news.

FB

Facebook

$177.07

-3.03 (-1.68%)

06:01
09/30/19
09/30
06:01
09/30/19
06:01

Facebook, WhatsApp must share messages with U.K. police, Bloomberg says

Social media platforms based in the U.S. including Facebook and WhatsApp will be forced to share messages with U.K. police in serious criminal investigations, Bloomberg's Kitty Donaldson and Mark Burton report, citing a person familiar with the matter. The accord is set to be signed by next month, according to the person. Reference Link

  • 27

    Oct

FB Facebook
$177.07

-3.03 (-1.68%)

09/10/19
OPCO
09/10/19
NO CHANGE
OPCO
Perform
Facebook dating survey suggests potential risk for Match Group, says Oppenheimer
Oppenheimer analyst Jason Helfstein surveyed 440 singles to gauge early response to Facebook (FB) Dating, and results highlighted that 40% of respondents were aware of the Facebook Dating product within 48 hours of initial launch in the U.S. Conversion of "aware" users was 15%, and the analyst expects awareness to grow significantly, yielding double digit penetration if the conversion ratio holds. Survey results point to a younger than expected user base, putting Facebook Dating in direct competition with Tinder, he contends. While historical download-data of initial Facebook Dating points to minimal Tinder impact, Helfstein notes that survey results make a compelling argument for near-term headwinds to Match Group (MTCH) shares, coupled with adverse short-term effects from a potential spin of. The analyst has a Perform rating on Match Group's shares.
09/10/19
GUGG
09/10/19
NO CHANGE
GUGG
Guggenheim sees no evidence of Facebook Dating hurting Match's Tinder
Facebook (FB) Dating is now live in 20 countries and Guggenheim analyst Jake Fuller, in a research note earlier to investors, said he cannot find an example where Match Group's Tinder "took a hit." Further, the analyst points out that Facebook Dating has been live in Canada since November 2018 and that his firm's data shows Tinder daily active users up 45% and downloads up 51% since the launch. Strong" Tinder downloads yield the potential for upside to consensus estimates when Match reports Q3 results, the analyst writes. Despite the launch of Facebook Dating in the U.S., the analyst says his perspective on Match is improving. Nonetheless, Fuller kept a Neutral rating on shares of Match Group, whose stock is down 10c to $77.86 in morning trading.
09/17/19
SUSQ
09/17/19
UPGRADE
Target $18
SUSQ
Neutral
Susquehanna upgrades Snap to Neutral after positive advertising checks
Susquehanna analyst Shyam Patil upgraded Snap (SNAP) to Neutral from Negative and boosted his price target for the shares to $18 from $12. The stock closed Monday down 24c to $15.76. The analyst's recent advertising channel checks have suggested that Snap's "solid" growth has continued in Q3 with expectations for continued progress in Q4. The checks also show that Facebook's (FB) Instagram Stories "has lowered barriers" for SNAP Stories adoption, Patil tells investors in a research note. The analyst, who also expect Snap's net addition momentum to continue in the second half of 2019, says the stock's valuation is keeping him from getting even more constructive.
09/27/19
SRCH
09/27/19
INITIATION
SRCH
Buy
Facebook initiated with a Buy at Summit Insights

TODAY'S FREE FLY STORIES

VBLT

VBL Therapeutics

$1.26

0.005 (0.40%)

07:07
11/14/19
11/14
07:07
11/14/19
07:07
Hot Stocks
VBL Therapeutics continues to advance development of MOSPD2 antibodies »

VBL continues to advance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 21

    Nov

BTAI

BioXcel Therapeutics

$4.50

0.06 (1.35%)

07:07
11/14/19
11/14
07:07
11/14/19
07:07
Earnings
BioXcel Therapeutics reports Q3 EPS (57c), consensus (65c) »

"We are pleased with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

VBLT

VBL Therapeutics

$1.26

0.005 (0.40%)

07:06
11/14/19
11/14
07:06
11/14/19
07:06
Hot Stocks
VBL Therapeutics expects to begin NCI-sponsored trial of VB-111 by year-end »

An NCI-sponsored trial of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 21

    Nov

WMT

Walmart

$121.06

1.93 (1.62%)

07:06
11/14/19
11/14
07:06
11/14/19
07:06
Hot Stocks
Walmart reports Q3 U.S. SSS up 3.2% »

Q3 U.S. comp sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MITO

Stealth Biotherapeutics

$7.20

0.35 (5.11%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Earnings
Stealth Biotherapeutics reports Q3 EPS (4c), consensus (4c) »

"We're…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

BIIB

Biogen

$281.71

-9.67 (-3.32%)

, ALKS

Alkermes

$19.39

-0.5 (-2.51%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Hot Stocks
MS Society asks Biogen, Alkermes to keep Vumerity price raises below inflation »

The National Multiple…

BIIB

Biogen

$281.71

-9.67 (-3.32%)

ALKS

Alkermes

$19.39

-0.5 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBLT

VBL Therapeutics

$1.26

0.005 (0.40%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Hot Stocks
VBL Therapeutics expects cash to fund requirements for two years »

At September 30, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 21

    Nov

XCUR

Exicure

$2.45

-0.14 (-5.41%)

, AGN

Allergan

$181.56

-0.38 (-0.21%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Hot Stocks
Exicure, Allergan subsidiary enter collaboration to find hair loss treatments »

Exicure (XCUR) announced…

XCUR

Exicure

$2.45

-0.14 (-5.41%)

AGN

Allergan

$181.56

-0.38 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBLT

VBL Therapeutics

$1.26

0.005 (0.40%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Earnings
VBL Therapeutics reports Q3 EPS (14c), consensus (14c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 21

    Nov

WMT

Walmart

$121.06

1.93 (1.62%)

07:05
11/14/19
11/14
07:05
11/14/19
07:05
Earnings
Walmart reports Q3 adjusted EPS $1.16, consensus $1.09 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

TJX

TJX

$58.45

0.505 (0.87%)

, ROST

Ross Stores

$111.38

0.41 (0.37%)

07:04
11/14/19
11/14
07:04
11/14/19
07:04
Recommendations
TJX, Ross Stores, Burlington Stores, Nordstrom, Macy's analyst commentary  »

Guggenheim raises price…

TJX

TJX

$58.45

0.505 (0.87%)

ROST

Ross Stores

$111.38

0.41 (0.37%)

BURL

Burlington Stores

$199.23

-1.14 (-0.57%)

JWN

Nordstrom

$37.18

0.28 (0.76%)

M

Macy's

$16.06

-0.02 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 26

    Nov

LPTX

Leap Therapeutics

$1.17

-0.035 (-2.92%)

07:04
11/14/19
11/14
07:04
11/14/19
07:04
Earnings
Leap Therapeutics reports Q3 EPS (33c), consensus (33c) »

"The body of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIA

Viacom

$25.14

-0.615 (-2.39%)

, VIAB

Viacom

$22.04

-0.52 (-2.31%)

07:04
11/14/19
11/14
07:04
11/14/19
07:04
Earnings
Viacom reports Q4 adj. EPS 79c, consensus 75c »

Reports Q4 revenue…

VIA

Viacom

$25.14

-0.615 (-2.39%)

VIAB

Viacom

$22.04

-0.52 (-2.31%)

CBS

CBS

$36.84

-0.935 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 09

    Dec

FULC

Fulcrum Therapeutics

$8.40

0.405 (5.07%)

07:02
11/14/19
11/14
07:02
11/14/19
07:02
Hot Stocks
Fulcrum Therapeutics expects to file IND for FTX-6058 in mid-2020 »

n October 2019, Fulcrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

FULC

Fulcrum Therapeutics

$8.40

0.405 (5.07%)

07:02
11/14/19
11/14
07:02
11/14/19
07:02
Hot Stocks
Fulcrum Therapeutics expects cash to fund requirements into 3Q21 »

As of September 30, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

TRIP

TripAdvisor

$30.83

-0.87 (-2.74%)

, GOOGL

Alphabet Class A

$1,296.00

-1.18 (-0.09%)

07:01
11/14/19
11/14
07:01
11/14/19
07:01
Recommendations
TripAdvisor, Alphabet Class A, Alphabet analyst commentary  »

TripAdvisor price target…

TRIP

TripAdvisor

$30.83

-0.87 (-2.74%)

GOOGL

Alphabet Class A

$1,296.00

-1.18 (-0.09%)

GOOG

Alphabet

$1,298.00

-0.77 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

  • 26

    Nov

FULC

Fulcrum Therapeutics

$8.40

0.405 (5.07%)

07:01
11/14/19
11/14
07:01
11/14/19
07:01
Earnings
Fulcrum Therapeutics reports Q3 EPS (97c), consensus ($2.98) »

"This past quarter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AMRN

Amarin

$21.49

0.55 (2.63%)

07:00
11/14/19
11/14
07:00
11/14/19
07:00
Hot Stocks
Amarin announces Nasdaq halts trading of company's shares »

Amarin announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

GOOS

Canada Goose

$34.81

-4.245 (-10.87%)

06:59
11/14/19
11/14
06:59
11/14/19
06:59
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBIV

VBI Vaccines

$0.56

-0.0091 (-1.60%)

06:58
11/14/19
11/14
06:58
11/14/19
06:58
Initiation
VBI Vaccines initiated  »

VBI Vaccines initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$23.78

0.34 (1.45%)

06:57
11/14/19
11/14
06:57
11/14/19
06:57
Upgrade
Meritor rating change  »

Meritor upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIN

Linde plc

$207.61

1.815 (0.88%)

06:57
11/14/19
11/14
06:57
11/14/19
06:57
Recommendations
Linde plc analyst commentary  »

Linde plc price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$84.76

0.63 (0.75%)

, AZN

AstraZeneca

$47.84

0.76 (1.61%)

06:56
11/14/19
11/14
06:56
11/14/19
06:56
Hot Stocks
Merck, AstraZeneca: FDA accepts NDA, grants priority review for selumetinib »

AstraZeneca (AZN) and…

MRK

Merck

$84.76

0.63 (0.75%)

AZN

AstraZeneca

$47.84

0.76 (1.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 10

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

XCUR

Exicure

$2.45

-0.14 (-5.41%)

06:56
11/14/19
11/14
06:56
11/14/19
06:56
Hot Stocks
Breaking Hot Stocks news story on Exicure »

Exicure Inc trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$21.49

0.55 (2.63%)

06:55
11/14/19
11/14
06:55
11/14/19
06:55
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.